A look into the growing role of patient advocates in the European Medicines Agency (Europe’s version of the FDA).
Flexibility and goodwill have allowed patient involvement in the work of Europe’s drug regulators to develop at an impressive pace. But will they be enough to withstand the strains on the relationship
regrounding 
Recent Comments